SPRR2A and melanoma: Therefore, piggyBac modified mouse splenocytes expressing mIL-12 were capable of anti-tumor activity in an in vivo melanoma tumor model and had improved anti-tumor activity compared to splenocytes containing antigen specific T cells alone not expressing mIL-12.